FoundationOne® CDx gene profiling in Japanese pancreatic ductal adenocarcinoma patients: a single-institution experience

References

Page 1

	Year	Citations
Global cancer statistics Ahmedin Jemal, Freddie Bray CA A Cancer Journal for Clinicians	2011	55K
Global cancer statistics, 2012 Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, CA A Cancer Journal for Clinicians	2015	27.2K
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Cancer statistics, 2017 Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal CA A Cancer Journal for Clinicians Epidemiology Of CancerPopulation Health SciencesCancer RegistrationUnited StatesCancer Risk Factors	2017	14.9K
Cancer Statistics, 2010 Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu, CA A Cancer Journal for Clinicians	2010	12.6K
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Thierry Conroy, Françoise Desseigne, Marc Ychou, New England Journal of Medicine	2011	7.6K
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Dung T. Le, Jennifer N. Durham, Kellie N. Smith, Science Solid TumorsPd-1 BlockadeImmunologyPathologyMismatch Repair Deficiency	2017	6.4K
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, New England Journal of Medicine	2010	5.5K
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses Siân Jones, D. Williams Parsons, Jimmy Lin, Science EngineeringGeneticsPathologyCancer BiologyTumor Biology	2008	4K
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa, New England Journal of Medicine	2013	3.4K

Page 1